“Evaluation of Multiple Immunotherapies (including Arabinoxylan) Based on NK Cell Activity and CD4/CD8 Ratio in Cancer Patients”

The 3rd Annual Meeting of the Japanese Society for Complementary & Alternative Medicine & Treatment, Tokyo, Japan
K. Takahara (Nishi-Shinjuku Clinic) et al